Post

Gut Microbiome a Player in Response to Anti-PD-1 Cancer Immunotherapy

Post

From the Front Lines to the Frontiers of Defeating Breast Cancer with Elizabeth Mittendorf, MD, PhD

Post

Cancer and the microbiome: What’s old is new again

Post

Could Immunotherapy Lead the Way to Fighting Cancer?

Post

Funds from tech guru Parker speed Penn study of skin cancer

Post

Removing the Hidden Obstacle Holding Back New Cancer Therapies

Post

Jeff Bluestone interviewed on cancer immunotherapy

Post

Neon Therapeutics bags a $70M round for early-stage neoantigen research

Research Institution

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

Post

The double edge of cancer immunotherapy